Scientists hunt for clues to why lichen planus treatment fails
NCT ID NCT05330572
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 110 adults with lichen planus who are using topical steroids, the standard first treatment. Researchers will collect clinical details, saliva, blood, and tissue samples to identify factors linked to poor response. The goal is to understand why some patients don't improve, which could lead to better, personalized treatments in the future.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors predict which patients will benefit from topical steroids and lead to more personalized treatments for lichen planus.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly improve care. Results may not apply to all patients, and the factors identified may not lead to new treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LICHEN PLANUS OF VULVA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aberdeen Dental School
Aberdeen, AB25 2ZR, United Kingdom
-
University of Aberdeen
Aberdeen, Aberdeen, Scotland, AB24 3FX, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.